4457 related articles for article (PubMed ID: 18173375)
1. PD-1 and its ligands in tolerance and immunity.
Keir ME; Butte MJ; Freeman GJ; Sharpe AH
Annu Rev Immunol; 2008; 26():677-704. PubMed ID: 18173375
[TBL] [Abstract][Full Text] [Related]
2. The programmed death-1 ligand 1:B7-1 pathway restrains diabetogenic effector T cells in vivo.
Paterson AM; Brown KE; Keir ME; Vanguri VK; Riella LV; Chandraker A; Sayegh MH; Blazar BR; Freeman GJ; Sharpe AH
J Immunol; 2011 Aug; 187(3):1097-105. PubMed ID: 21697456
[TBL] [Abstract][Full Text] [Related]
3. Role of PD-1 and its ligand, B7-H1, in early fate decisions of CD8 T cells.
Goldberg MV; Maris CH; Hipkiss EL; Flies AS; Zhen L; Tuder RM; Grosso JF; Harris TJ; Getnet D; Whartenby KA; Brockstedt DG; Dubensky TW; Chen L; Pardoll DM; Drake CG
Blood; 2007 Jul; 110(1):186-92. PubMed ID: 17392506
[TBL] [Abstract][Full Text] [Related]
4. Blockade of programmed death-1 ligands on dendritic cells enhances T cell activation and cytokine production.
Brown JA; Dorfman DM; Ma FR; Sullivan EL; Munoz O; Wood CR; Greenfield EA; Freeman GJ
J Immunol; 2003 Feb; 170(3):1257-66. PubMed ID: 12538684
[TBL] [Abstract][Full Text] [Related]
5. Cutting Edge: Programmed death (PD) ligand-1/PD-1 interaction is required for CD8+ T cell tolerance to tissue antigens.
Martin-Orozco N; Wang YH; Yagita H; Dong C
J Immunol; 2006 Dec; 177(12):8291-5. PubMed ID: 17142723
[TBL] [Abstract][Full Text] [Related]
6. The novel costimulatory programmed death ligand 1/B7.1 pathway is functional in inhibiting alloimmune responses in vivo.
Yang J; Riella LV; Chock S; Liu T; Zhao X; Yuan X; Paterson AM; Watanabe T; Vanguri V; Yagita H; Azuma M; Blazar BR; Freeman GJ; Rodig SJ; Sharpe AH; Chandraker A; Sayegh MH
J Immunol; 2011 Aug; 187(3):1113-9. PubMed ID: 21697455
[TBL] [Abstract][Full Text] [Related]
7. Analysis of the role of negative T cell costimulatory pathways in CD4 and CD8 T cell-mediated alloimmune responses in vivo.
Ito T; Ueno T; Clarkson MR; Yuan X; Jurewicz MM; Yagita H; Azuma M; Sharpe AH; Auchincloss H; Sayegh MH; Najafian N
J Immunol; 2005 Jun; 174(11):6648-56. PubMed ID: 15905503
[TBL] [Abstract][Full Text] [Related]
8. The B7 family revisited.
Greenwald RJ; Freeman GJ; Sharpe AH
Annu Rev Immunol; 2005; 23():515-48. PubMed ID: 15771580
[TBL] [Abstract][Full Text] [Related]
9. PD-1 on immature and PD-1 ligands on migratory human Langerhans cells regulate antigen-presenting cell activity.
Peña-Cruz V; McDonough SM; Diaz-Griffero F; Crum CP; Carrasco RD; Freeman GJ
J Invest Dermatol; 2010 Sep; 130(9):2222-30. PubMed ID: 20445553
[TBL] [Abstract][Full Text] [Related]
10. Blockade of B7-H1 suppresses the development of chronic intestinal inflammation.
Kanai T; Totsuka T; Uraushihara K; Makita S; Nakamura T; Koganei K; Fukushima T; Akiba H; Yagita H; Okumura K; Machida U; Iwai H; Azuma M; Chen L; Watanabe M
J Immunol; 2003 Oct; 171(8):4156-63. PubMed ID: 14530338
[TBL] [Abstract][Full Text] [Related]
11. Role of PD-L1 and PD-L2 in allergic diseases and asthma.
Singh AK; Stock P; Akbari O
Allergy; 2011 Feb; 66(2):155-62. PubMed ID: 20722638
[TBL] [Abstract][Full Text] [Related]
12. The PD-1/PD-L1 pathway in human pathology.
Saresella M; Rainone V; Al-Daghri NM; Clerici M; Trabattoni D
Curr Mol Med; 2012 Mar; 12(3):259-67. PubMed ID: 22300137
[TBL] [Abstract][Full Text] [Related]
13. Control of peripheral T-cell tolerance and autoimmunity via the CTLA-4 and PD-1 pathways.
Fife BT; Bluestone JA
Immunol Rev; 2008 Aug; 224():166-82. PubMed ID: 18759926
[TBL] [Abstract][Full Text] [Related]
14. Expression of programmed death 1 ligands by murine T cells and APC.
Yamazaki T; Akiba H; Iwai H; Matsuda H; Aoki M; Tanno Y; Shin T; Tsuchiya H; Pardoll DM; Okumura K; Azuma M; Yagita H
J Immunol; 2002 Nov; 169(10):5538-45. PubMed ID: 12421930
[TBL] [Abstract][Full Text] [Related]
15. Differential binding properties of B7-H1 and B7-DC to programmed death-1.
Youngnak P; Kozono Y; Kozono H; Iwai H; Otsuki N; Jin H; Omura K; Yagita H; Pardoll DM; Chen L; Azuma M
Biochem Biophys Res Commun; 2003 Aug; 307(3):672-7. PubMed ID: 12893276
[TBL] [Abstract][Full Text] [Related]
16. The function of programmed cell death 1 and its ligands in regulating autoimmunity and infection.
Sharpe AH; Wherry EJ; Ahmed R; Freeman GJ
Nat Immunol; 2007 Mar; 8(3):239-45. PubMed ID: 17304234
[TBL] [Abstract][Full Text] [Related]
17. Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation.
Freeman GJ; Long AJ; Iwai Y; Bourque K; Chernova T; Nishimura H; Fitz LJ; Malenkovich N; Okazaki T; Byrne MC; Horton HF; Fouser L; Carter L; Ling V; Bowman MR; Carreno BM; Collins M; Wood CR; Honjo T
J Exp Med; 2000 Oct; 192(7):1027-34. PubMed ID: 11015443
[TBL] [Abstract][Full Text] [Related]
18. The PD-1 pathway in tolerance and autoimmunity.
Francisco LM; Sage PT; Sharpe AH
Immunol Rev; 2010 Jul; 236():219-42. PubMed ID: 20636820
[TBL] [Abstract][Full Text] [Related]
19. The role of the PD-1 pathway in autoimmunity and peripheral tolerance.
Fife BT; Pauken KE
Ann N Y Acad Sci; 2011 Jan; 1217():45-59. PubMed ID: 21276005
[TBL] [Abstract][Full Text] [Related]
20. Tissue expression of PD-L1 mediates peripheral T cell tolerance.
Keir ME; Liang SC; Guleria I; Latchman YE; Qipo A; Albacker LA; Koulmanda M; Freeman GJ; Sayegh MH; Sharpe AH
J Exp Med; 2006 Apr; 203(4):883-95. PubMed ID: 16606670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
